April 27, 2021 Dr. Ralph Baric is one of four professors at UNC-Chapel Hill newly inducted into the National Academy of Sciences — one of the highest distinctions for a scientist or engineer in the United States.
April 20, 2021 While the United States is the world’s biggest funder of AIDS research and programs, it is also the only high-income member of the top 10 most HIV-affected countries. With this in mind, Dr. Adaora Adimora and co-authors have highlighted important recent developments concerning HIV epidemiology, comorbidities, treatment and prevention among women in the U.S.
April 5, 2021 In a new commentary, Gillings School epidemiologists call for an approach to monitoring COVID-19 data that compares risks across racial and ethnic demographics in order to create a more equitable response to the pandemic.
March 29, 2021 A clinical trial at U.S. college campuses, co-led by Dr. Audrey Pettifor, will test if COVID-19 vaccines prevent the spread of SARS-CoV-2.
March 18, 2021 As part of The Lancet’s Commission on COVID-19 Vaccines and Therapeutics Task Force, Dr. Timothy Sheahan has contributed to a new primer for health care providers addressing common misinformation about COVID-19 vaccines.
February 18, 2021 In a peer-reviewed article published in the American Journal of Public Health, leading scientists and health professionals identify ortho-phthalates as neurotoxic chemicals that increase children's risks for learning, attention and behavioral disorders. In particular, prenatal exposures to phthalates can contribute to attention problems in children.
February 9, 2021 Using a novel in vivo research model containing human lung tissue, UNC Gillings School of Global Public Health and UNC School of Medicine scientists demonstrated that the experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection.
Activity trackers may help patients maintain physical activity after cardiac rehabilitation discharge
February 4, 2021 A new study that includes research from Dr. Kelly Evenson suggests that activity trackers could help patients maintain necessary levels of physical activity after they are discharged from outpatient cardiac rehabilitation.
January 21, 2021 In response to the COVID-19 pandemic, scientists at UNC teamed up to create the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI) to not only combat SARS-CoV-2 but also future viral outbreaks.
UNC road safety research explores strengthening Vision Zero plans to support injury reductions and health improvements
December 16, 2020 Local leaders now have a comprehensive guide for enacting Vision Zero plans to increase safe, healthy and equitable mobility in their own communities thanks to research from UNC and the Collaborative Sciences Center for Road Safety.